Dentium CO., LTD (KRX: 145720)

Market Cap	501.05B
Revenue (ttm)	412.39B
Net Income (ttm)	95.41B
Shares Out	8.62M
EPS (ttm)	11,063.30
PE Ratio	5.25
Forward PE	5.85
Dividend	400.00 (0.72%)
Ex-Dividend Date	Dec 27, 2024

Volume	70,239
Open	56,300
Previous Close	56,300
Day's Range	54,000 - 56,400
52-Week Range	54,000 - 148,500
Beta	0.88
Analysts	n/a
Price Target	n/a
Earnings Date	Nov 6, 2024

About Dentium CO., LTD

Dentium CO., LTD manufactures and sells dental medical instrument worldwide. Its implant systems include superline, implantium, implantium 2, N.R. line, simple line 2, and slim line. The company also provides block and coloring; regeneration products; and digital dentistry products. In addition, it offers orthodontics, bright resin, tooth care, and other dental products. The company was formerly known as Biostech Co., Ltd. and changed its name to Dentium Co.,Ltd. in August 2002. Dentium Co.,Ltd. was founded in 2000 and is headquartered in Seoul...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• Founded: 2000
• Employees: 827
• Stock Exchange: Korea Stock Exchange
• Ticker Symbol: 145720

Financial Performance

In 2023, Dentium CO., LTD's revenue was 393.19 billion, an increase of 10.49% compared to the previous year's 355.87 billion. Earnings were 96.52 billion, an increase of 12.15%.